Description

BSE announces listing of 60,00,000 new equity shares of Titan Intech Limited issued on a preferential basis via conversion of warrants, effective March 2, 2026.

Summary

BSE Notice No. 20260227-29 informs trading members that 60,00,000 new equity shares of Titan Intech Limited (Scrip Code: 521005) are listed and permitted to trade on the Exchange with effect from Monday, March 2, 2026. The shares were issued to non-promoters on a preferential basis pursuant to conversion of warrants.

Key Points

  • 60,00,000 equity shares of Re. 1/- each issued at a premium of Rs. 4.50 (issue price Rs. 5.50 per share)
  • Issued to non-promoters on a preferential basis via conversion of warrants
  • Shares rank pari-passu with existing equity shares
  • Distribution numbers: 828576883 to 834576882
  • ISIN: INE807M01031
  • Date of allotment: January 24, 2026
  • Trading permitted from March 2, 2026

Regulatory Changes

No regulatory changes. This is a routine listing notification following a preferential allotment under existing SEBI regulations governing warrant conversion.

Compliance Requirements

  • Trading members must update their systems to reflect the new securities available for trading from March 2, 2026
  • All 60,00,000 shares are subject to lock-in until October 20, 2026 and must not be traded until that date

Important Dates

  • Date of Allotment: January 24, 2026
  • Trading Commencement: March 2, 2026 (Monday)
  • Lock-in Expiry: October 20, 2026 (for all 60,00,000 shares, Dist. Nos. 828576883 to 834576882)

Impact Assessment

Limited market impact. The addition of 60,00,000 shares represents a modest increase in the float for Titan Intech Limited (Scrip Code: 521005). All newly listed shares are under lock-in until October 20, 2026, meaning no immediate increase in tradeable supply. Market participants should note the lock-in expiry date as a potential future liquidity event.

Impact Justification

Routine listing of new equity shares from preferential allotment via warrant conversion for a single company; no broad market or regulatory implications.